Medical oversight, or the lack of it, has exposed a serious health inequity for many in Hawaii’s diverse population.

First Commercial Sales: Humacyte commenced its commercial launch of Symvess in late February 2025 after the first commercial batch was released by the FDA. The first commercial shipments containing ...